Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.040
+0.020 (1.96%)
At close: May 13, 2026, 4:00 PM EDT
1.030
-0.010 (-0.96%)
After-hours: May 13, 2026, 7:33 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $3.96 million as of May 13, 2026. Its market cap has decreased by -9.55% in one year.
Market Cap
3.96M
Enterprise Value
1.32M
1-Year Change
-9.55%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $3.96M, a decrease of -99.65%. That is a compound annual growth rate of -68.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 3.88M | -43.91% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 4.57M |
| Akari Therapeutics, | 4.42M |
| Indaptus Therapeutics | 4.11M |
| Matinas BioPharma Holdings | 4.04M |
| GeoVax Labs | 4.04M |
| 60 Degrees Pharmaceuticals | 3.94M |
| Revelation Biosciences | 3.85M |
| VivoSim Labs | 3.85M |